| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 2.6 | 1.7 |
| Gross profit | 1.2 | 0.6 |
| Profit before tax | 0.3 | -0.2 |
| Net income | 0.3 | -0.2 |
| EPS (diluted, $ a share) | $0.02 | $-0.02 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | +51.5% |
|---|---|
| Gross margin | 46.3% |
| Operating margin | 11.7% |
10-Q filed with the SEC, OTC: SYRA. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Syra Health Corp: key numbers
- Share price
- $0.7600Close, Nov 16
- Market cap
- $10.5M
- Shares outstanding
- 13.85MLatest SEC cover page
- Sector
- Trade & Services
- Industry
- Services-Employment AgenciesSIC 7361
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Syra Health Corp
All →Syra Health Financial Results
Syra Health reported its third consecutive profitable quarter with record revenue of $2.6 million, a 52% increase year-over-year. The company achieved a record gross margin of 46.3% and positive net income of $0.34 million, compared to a loss in the prior year period.
- Term
- Q3 2026